Exposure of membrane phosphatidylserine and platelet procoagulant activity;Exposition membranaire de la phosphatidylsérine et activité procoagulante des plaquettes

Hematologie

Volumn 13, Issue 2, 2007, Pages 94-109

  Kerbiriou Nabias, Danièle ^a   Geldwerth Feniger, Danielle ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Coagulation; Haemostasis; Lymphocytes; Phosphatidylserine; Plasma membrane; Platelets; Scott syndrome

Indexed keywords

ABC TRANSPORTER; PHOSPHATIDYLSERINE; SCRAMBLASE;

CELL MEMBRANE; HEMATOPOIETIC STEM CELL; HEMOSTASIS; HUMAN; LIPID TRANSPORT; PHENOTYPE; REVIEW; SCOTT SYNDROME; THROMBOCYTE FUNCTION; THROMBOSIS;

EID: 34250715825     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: 10.1684/hma.2007.0138     Document Type: Review

References (91)

1. Vereb G, Szollosi J, Matko J, Nagy P, Farkas T, Vigh L, Matyus L, Waldmann TA, Damjanovich S. Dynamic, yet structured : The cell membrane three decades after the Singer-Nicolson model. Proc Natl Acad Sci USA 2003 ; 100 : 8053-8.
2. Bevers EM, Comfurius P, Zwaal RF. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983 ; 736 : 57-66.
3. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome : an isolated defect in platelet procoagulant activity. J Biol Chem 1989 ; 264 : 17049-57.
4. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997 ; 89 : 1121-32.
5. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988 ; 263 : 18205-12.
6. Rosing J, van Rijn JL, Bevers EM, van Dieijen G, Comfurius P, Zwaal RF. The role of activated human platelets in prothrombin and factor X activation. Blood 1985 ; 65 : 319-32.
7. Wolfs JL, Comfurius P, Rasmussen JT, Keuren JF, Lindhout T, Zwaal RF, Bevers EM. Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction. Cell Mol Life Sci 2005 ; 62 : 1514-25.
8. Green DR. Apoptotic pathways : the roads to ruin. Cell 1998 ; 94 : 695-8.
9. Kozian D, Proulle V, Nitsche A, Galitzine M, Martinez MC, Schumann B, Meyer D, Herrmann M, Freyssinet JM, Kerbiriou-Nabias D. Identification of genes involved in Ca2+ ionophore A23187-mediated apoptosis and demonstration of a high susceptibility for transcriptional repression of cell cycle genes in B lymphoblasts from a patient with Scott syndrome. BMC Genomics 2005 ; 6 : 146.
10. Devaux PF, Fellmann P, Herve P. Investigation on lipid asymmetry using lipid probes : Comparison between spin-labeled lipids and fluorescent lipids. Chem Phys Lipids 2002 ; 116 : 115-34.
11. London FS, Marcinkiewicz M, Walsh PN. A subpopulation of platelets responds to thrombin- or SFLLRN-stimulation with binding sites for factor IXa. J Biol Chem 2004 ; 279 : 19854-9.
12. Tait JF, Gibson D, Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 1989 ; 264 : 7944-9.
13. Aupeix K, Toti F, Satta N, Bischoff P, Freyssinet JM. Oyxsterols induce membrane procoagulant activity in monocytic THP-1 cells. Biochem J 1996 ; 314 : 1027-33.
14. Dasgupta SK, Guchhait P, Thiagarajan P. Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5. Transl Res 2006 ; 148 : 19-25.
15. Taylor MR, Couto JR, Scallan CD, Ceriani RL, Peterson JA. Lactadherin (formerly BA46), a membrane-associated glycoprotein expressed in human milk and breast carcinomas, promotes Arg-Gly-Asp (RGD)-dependent cell adhesion. DNA Cell Biol 1997 ; 16 : 861-9.
16. Zweifach A. FM1-43 reports plasma membrane phospholipid scrambling in T-lymphocytes. Biochem J 2000 ; 349 : 255-60.
17. Seigneuret M, Devaux PF. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane : relation to shape changes. Proc Natl Acad Sci USA 1984 ; 81 : 3751-5.
18. Devaux PF, Lopez-Montero I, Bryde S. Proteins involved in lipid translocation in eukaryotic cells. Chem Phys Lipids 2006 ; 141 : 119-32.
19. Bitbol M, Devaux PF. Measurement of outward translocation of phospholipids across human erythrocyte membrane. Proc Natl Acad Sci USA 1988 ; 85 : 6783-7.
20. Connor J, Pak CH, Zwaal RF, Schroit AJ. Bidirectional transbilayer movement of phospholipid analogs in human red blood cells. Evidence for an ATP-dependent and protein-mediated process. J Biol Chem 1992 ; 267 : 19412-7.
21. Dekkers DW, Comfurius P, Schroit AJ, Bevers EM, Zwaal RF. Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes : outward-directed transport by the multidrug resistance protein 1 (MRP 1). Biochemistry 1998 ; 37 : 14833-7.
22. Smeets EF, Comfurius P, Bevers EM, Zwaal RF. Calcium-induced transbilayer scrambling of fluorescent phospholipid analogs in platelets and erythrocytes. Biochim Biophys Acta 1994 ; 1195 : 281-6.
23. Williamson P, Bevers EM, Smeets EF, Comfurius P, Schlegel RA, Zwaal RF. Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry 1995 ; 34 : 10448-55.
24. Basse F, Gaffet P, Rendu F, Bienvenue A. Translocation of spin-labeled phospholipids through plasma membrane during thrombin- and ionophore A23187-induced platelet activation. Biochemistry 1993 ; 32 : 2337-44.
25. Gaffet P, Bettache N, Bienvenue A. Transverse redistribution of phospholipids during human platelet activation : evidence for a vectorial outflux specific to aminophospholipids. Biochemistry 1995 ; 34 : 6762-9.
26. Kuypers FA, Lewis RA, Hua M, Schott MA, Discher D, Ernst JD, Lubin BH. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood 1996 ; 87 : 1179-87.
27. Weiss HJ, Vicic WJ, Lages BA, Rogers J. Isolated deficiency of platelet procoagulant activity. Am J Med 1979 ; 67 : 206-13.
28. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 1996 ; 87 : 1409-15.
29. Higgins CF, Gottesman MM. Is the multidrug transporter a flippase? Trends Biochem Sci 1992 ; 17: 18-21.
30. Pohl A, Devaux PF, Herrmann A. Function of prokaryotic and eukaryotic ABC proteins in lipid transport. Biochim Biophys Acta 2005 ; 1733 : 29-52.
31. Pohl A, Lage H, Müller P, Pomorski T, Herrmann A. Transport of phosphatidylserine via MDR1 (multidrug resistance 1)P-glycoprotein in a human gastric carcinoma cell line. Biochem J 2002 ; 365 : 259-68.
32. Woehlecke H, Pohl A, Alder-Baerens N, Lage H, Herrmann A. Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2). Biochem J 2003 ; 376 : 489-95.
33. Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S, Freyssinet JM, Devaux PF, McNeish J, Marguet D, Chimini G. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol 2000 ; 2 : 399-406.
34. Alder-Baerens N, Müller P, Pohl A, Korte T, Hamon Y, Chimini G, Pomorski T, Herrmann A. Headgroup-specific exposure of phospholipids in ABCA1-expressing cells. J Biol Chem 2005 ; 280 : 26321-9.
35. Orso E, Broccardo C, Kaminski WE, Bottcher A, Liebisch G, Drobnik W, Gotz A, Chambenoit O, Diederich W, Langmann T, Spruss T, Luciani MF, Rothe G, Lackner KJ, Chimini G, Schmitz G. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nat Genet 2000 ; 24 : 192-6.
36. Elliott JI, Sordini A, Cooper JC, Alexander DR, Davanture S, Chimini G, Higgins CF. Phosphatidylserine exposure in B lymphocytes : a role for lipid packing. Blood 2006 ; 108 : 1611-7.
37. Probst MC, Thumann H, Aslanidis C, Langmann T, Buechler C, Patsch W, Baralle FE, Dallinga-Thie GM, Geisel J, Keller C, Menys VC, Schmitz G. Screening for functional sequence variations and mutations in ABCA1. Atherosclerosis 2004 ; 175 : 269-79.
38. Nofer JR, Herminghaus G, Brodde M, Morgenstern E, Rust S, Engel T, Seedorf U, Assmann G, Bluethmann H, Kehrel BE. Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease). J Biol Chem 2004 ; 279 : 34032-7.
39. Albrecht C, McVey JH, Elliott JI, Sordini A, Kasza I, Mumford AD, Naoumova RP, Tuddenham EG, Szabo K, Higgins CF. A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome. Blood 2005 ; 106 : 542-9.
40. Sjölinder M, Tornhamre S, Claesson HE, HydmanJ, Lindgren J. Characterization of a leukotriene C4 export mechanism in human platelets : possible involvement of multidrug resistance-associated protein 1. J Lipid Res 1999 ; 40 : 439-46.
41. Comfurius P, Williamson P, Smeets EF, Schlegel RA, Bevers EM, Zwaal RF. Reconstitution of phospholipid scramblase activity from human blood platelets. Biochemistry 1996 ; 35 : 7631-4.
42. Bassé F, Stout JG, Sims PJ, Wiedmer T. Isolation of an erythrocyte membrane protein that mediates Ca2+-dependent transbilayer movement of phospholipid. J Biol Chem 1996 ; 271 : 17205-10.
43. Zhou Q, Zhao J, Stout JG, Luhm RA, Wiedmer T, Sims PJ. Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids. J Biol Chem 1997 ; 272 : 18240-4.
44. Zhao J, Zhou Q, Wiedmer T, Sims PJ. Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface. J Biol Chem 1998 ; 273 : 6603-6.
45. Stout JG, Bassé F, Luhm RA, Weiss HJ, Wiedmer T, Sims PJ. Scott syndrome erythrocytes contain a membrane protein capable of mediating Ca2+-dependent transbilayer migration of membrane phospholipids. J Clin Invest 1997 ; 99 : 2232-8.
46. Janel N, Leroy C, Laude I, Toti F, Fressinaud E, Meyer D, Freyssinet JM, Kerbiriou-Nabias D. Assessment of the expression of candidate human plasma membrane phospholipid scramblase in Scott syndrome cells. Thromb Haemost 1999 ; 81 : 322-3.
47. Zhou Q, Ben-Efraim I, Bigcas JL, Junqueira D, Wiedmer T, Sims PJ. Phospholipid scramblase 1 binds to the promoter region of the inositol 1,4,5-triphosphate receptor type 1 gene to enhance its expression. J Biol Chem 2005 ; 280 : 35062-8.
48. Wiedmer T, Zhou Q, Kwoh DY, Sims PJ. Identification of three new members of the phospholipid scramblase gene family. Biochim Biophys Acta 2000 ; 1467 : 244-53.
49. Wiedmer T, Zhao J, Li L, Zhou Q, Hevener A, Olefsky JM, Curtiss LK, Sims PJ. Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3). Proc Natl Acad Sci USA 2004 ; 101 : 13296-301.
50. Schrier SL, Zachowski A, Herve P, Kader JC, Devaux PF. Transmembrane redistribution of phospholipids of the human red cell membrane during hypotonic hemolysis. Biochim Biophys Acta 1992 ; 1105 : 170-6.
51. Vanags DM, Orrenius S, Aguilar-Santelises M. Alterations in Bcl-2/Bax protein levels in platelets form part of an ionomycin-induced process that resembles apoptosis. Br J Haematol 1997 ; 99 : 824-31.
52. Leytin V, Allen DJ, Mykhaylov S, Lyubimov E, Freedman J. Thrombin-triggered platelet apoptosis. J Thromb Haemost 2006 ; 4 : 2656-63.
53. Augereau O, Rossignol R, DeGiorgi F, Mazat JP, Letellier T, Dachary-Prigent J. Apoptotic-like mitochondrial events associated to phosphatidylserine exposure in blood platelets induced by local anaesthetics. Thromb Haemost 2004 ; 92 : 104-13.
54. Dale GL, Friese P. Bax activators potentiate coated-platelet formation. J Thromb Haemost 2006 ; 4 : 2664-9.
55. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000 ; 1 : 11-21.
56. Thastrup O, Cullen PJ, Drobak BK, Hanley MR, Dawson AP. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci USA 1990 ; 87 : 2466-70.
57. Dachary-Prigent J, Pasquet JM, Freyssinet JM, Nurden AT. Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation : a study using Ca2+-ATPase inhibitors. Biochemistry 1995 ; 34 : 11625-34.
58. Smeets EF, Heemskerk JW, Comfurius P, Bevers EM, Zwaal RF. Thapsigargin amplifies the platelet procoagulant response caused by thrombin. Thromb Haemost 1993 ; 70 : 1024-9.
59. Martin S, Laude-Lemaire I, Kerbiriou-Nabias D, Freyssinet JM, Martinez MC. Relation between phosphatidylserine exposure and store-operated Ca(2+) entry in stimulated cells. Biochem Biophys Res Commun 2000 ; 279 : 639-45.
60. Wurth GA, Zweifach A. Evidence that cytosolic calcium increases are not sufficient to stimulate phospholipid scrambling in human T-lymphocytes. Biochem J 2002 ; 362 : 701-8.
61. Munnix IC, Harmsma M, Giddings JC, Collins PW, Feijge AAA, Comfurius P, Heemskerk JW, Bevers EM. Store-mediated calcium entry in the regulation of phosphatidylserine exposure in blood cells from Scott patients. Thromb Haemost 2003 ; 89 : 687-95.
62. Galitzine M, Capiod T, Le Deist F, Meyer D, Freyssinet JM, Kerbiriou-Nabias D. Ca2+ ionophores trigger membrane remodeling without a need for store-operated Ca2+ entry. Biochem Biophys Res Commun 2005 ; 327 : 335-41.
63. Partiseti M, Le Deist F, Hivroz C, Fischer A, Korn H, Choquet D. The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency. J Biol Chem 1994 ; 269 : 32327-35.
64. Futami T, Miyagishi M, Taira K. Identification of a network involved in thapsigargin-induced apoptosis using a library of small interfering RNA expression vectors. J Biol Chem 2005 ; 280 : 826-31.
65. Pasquet JM, Dachary-Prigent J, Nurden AT. Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen. Biochem J 1998 ; 333 : 591-9.
66. Heemskerk JW, Vuist WM, Feijge MA, Reutelingsperger CP, Lindhout T. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets : evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses. Blood 1997 ; 90 : 2615-25.
67. Siljander P, Farndale RW, Feijge MA, Comfurius P, Kos S, Bevers EM, Heemskerk JW. Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response : Involvement of p38 MAP kinase and calpain. Arterioscler Thromb Vasc Biol 2001 ; 21 : 618-27.
68. Imam-Sghiouar N, Laude-Lemaire I, Labas V, Pflieger D, Le Caer JP, Caron M, Kerbiriou-Nabias D, Joubert-Caron R. Subproteomics analysis of phosphorylated proteins : application to the study of B-lymphoblasts from a patient with Scott syndrome. Proteomics 2002 ; 2 : 828-38.
69. Kunzelmann-Marche C, Freyssinet JM, Martinez MC. Loss of plasma membrane phospholipid asymmetry requires raft integrity. Role of transient receptor potential channels and ERK pathway. J Biol Chem 2002 ; 277 : 19876-81.
70. Verhallen PF, Bevers EM, Comfurius P, Zwaal RF. Correlation between calpain-mediated cytoskeletal degradation and expression of platelet procoagulant activity. A role for the platelet membrane-skeleton in the regulation of membrane lipid asymmetry? Biochim Biophys Acta 1987 ; 903 : 206-17.
71. Fox JE, Austin CD, Boyles JK, Steffen PK. Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane. J Cell Biol 1990 ; 111 : 483-93.
72. Kunzelmann-Marche C, Freyssinet JM, Martinez MC. Regulation of phosphatidylserine transbilayer redistribution by store-operated Ca2+ entry : role of actin cytoskeleton. J Biol Chem 2001 ; 276 : 5134-9.
73. Kuypers FA, Lubin BH, Yee M, Agre P, Devaux PF, Geldwerth D. The distribution of erythrocyte phospholipids in hereditary spherocytosis demonstrates a minimal role for erythrocyte spectrin on phospholipid diffusion and asymmetry. Blood 1993 ; 81 : 1051-7.
74. Gaffet P, Bettache N, Bienvenue A. Phosphatidylserine exposure on the platelet plasma membrane during A23187-induced activation is independent of cytoskeleton reorganization. Eur J Cell Biol 1995 ; 67 : 336-45.
75. Laude-Lemaire I, Martinez MC, Leclerc P, Papp B, Galitzine M, Meyer D, Freyssinet JM, Kerbiriou-Nabias D. Procoagulant phosphatidylserine externalization defect of Scott syndrome is related to altered intracellular signaling, subsequent to actin polymerisation and calcium release. Thromb Haemost 2001 (Suppl. 1).
76. Gemmell CH, Sefton MV, Yeo EL. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RODS and a Glanzmann's thrombasthenia defect. J Biol Chem 1993 ; 268 : 14586-9.
77. Haga JH, Slack SM, Jennings LK. Comparison of shear stress-induced platelet microparticle formation and phosphatidylserine expression in presence of alphaIIbbeta3 antagonists. J Cardiovasc Pharmacol 2003 ; 41 : 363-71.
78. Reininger AJ, Heijnen HF, Schumann H, Specht HM, Schramm W, Ruggeri ZM. Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood 2006 ; 107 : 3537-45.
79. Andersen H, Greenberg DL, Fujikawa K, Xu W, Chung DW, Davie EW. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. Proc Natl Acad Sci USA 1999 ; 96 : 11189-93.
80. Keuren JF, Wielders SJ, Ulrichts H, Hackeng T, Heemskerk JW, Deckmyn H, Bevers EM, Lindhout T. Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1. Arterioscler Thromb Vasc Biol 2005 ; 25 : 1499-505.
81. Heemskerk JW, Siljander P, Vuist WM, Breikers G, Reutelingsperger CP, Barnes MJ, Knight CG, Lassila R, Farndale RW. Funcfion of glycoprotein VI and integrin alpha2beta1 in the procoagulant response of single, collagen-adherent platelets. Thromb Haemost 1999 ; 81 : 782-92.
82. Sulpice JC, Zachowski A, Devaux PF, Giraud F. Requirement for phosphatidylinositol 4,5-bisphosphate in the Ca(2+)-induced phospholipid redistribution in the human erythrocyte membrane. J Biol Chem 1994 ; 269 : 6347-54.
83. Bucki R, Giraud F, Sulpice JC. Phosphatidylinositol 4,5-bisphosphate domain inducers promote phospholipid transverse redistribution in biological membranes. Biochemistry 2000 ; 39 : 5838-44.
84. Bevers EM, Wiedmer T, Comfurius P, Zhao J, Smeets EF, Schlegel RA, Schroit AJ, Weiss HJ, Williamson P, Zwaal RF, Sims PJ. The complex of phosphatidylinositol 4,5-bisphosphate and calcium ions is not responsible for Ca2+-induced loss of phospholipid asymmetry in the human erythrocyte : a study in Scott syndrome, a disorder of calcium-induced phospholipid scrambling. Blood 1995 ; 86 : 1983-91.
85. Bucki R, Janmey PA, Vegners R, Giraud F, Sulpice JC. Involvement of phosphatidylinositol 4,5-bisphosphate in phosphatidylserine exposure in platelets : use of a permeant phosphoinositide-binding peptide. Biochemistry 2001 ; 40 : 15752-61.
86. Bucki R, Pastore JJ, Giraud F, Janmey PA, Sulpice JC. Involvement of the Na+/H+ exchanger in membrane phosphatidylserine exposure during human platelet activation. Biochim Biophys Acta 2006 ; 1761 : 195-204.
87. Wolfs JL, Wielders SJ, Comfurius P, Lindhout T, Giddings JC, Zwaal RF, Bevers EM. Reversible inhibition of the platelet procoagulant response through manipulation of the Gardos channel. Blood 2006 ; 108 : 2223-8.
88. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997 ; 387 : 569-72.
89. Frasch SC, Henson PM, Nagaosa K, Fessler MB, Borregaard N, Bratton DL. Phospholipid flip-flop and phospholipid scramblase 1 (PLSCR1) co-localize to uropod rafts in formylated Met-Leu-Phe-stimulated neutrophils. J Biol Chem 2004 ; 279 : 17625-33.
90. Ishii H, Mori T, Shiratsuchi A, Nakai Y, Shimada Y, Ohno-Iwashita Y, Nakanishi Y. Distinct localization of lipid rafts and externalized phosphatidylserine at the surface of apoptotic cells. Biochem Biophys Res Commun 2005 ; 327 : 94-9.
91. Lentz BR. Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res 2003 ; 42 : 423-38.